Exhibit 39 - Cal Yr 2024 City of Miami Stop Loss - High Claimant Report De-ID Dx.xlsx
XLSX spreadsheet 57 KB Posted
- Attached to
- RFP No. 2130386 - Employee Health Benefits Plan
- Solicitation number
- RFP No. 2130386 - Employee Health Benefits Plan
- Issued by
- Florida
About this file
This document is an Excel spreadsheet titled "Exhibit 39 - Cal Yr 2024 City of Miami Stop Loss - High Claimant Report De-ID Dx" containing detailed de-identified medical claims data for the City of Miami's employee health benefits plan. The report covers claims exceeding $50,000 for the calendar year 2024, utilizing a pooled stop-loss and retrospective experience-rated approach for various employee groups including active general employees, sea employees, and executives/elected officials.
The spreadsheet provides granular claims information organized by benefit plan (OAPAE-OAP and NPOS), employee category, gender, age band, and specific medical diagnoses with corresponding ICD codes. Claims data includes pharmacy and medical expenses, broken down by individual claimants across different age ranges and medical conditions such as prostate cancer, appendicitis, end-stage renal disease, and various other medical treatments. The document appears to be a supporting exhibit for RFP No. 2130386, which solicits proposals for the City of Miami's employee health benefits plan, demonstrating detailed claims history to inform potential insurers or third-party administrators about the healthcare utilization of the city's workforce.
View the file
Other files
Show 40 more
Latest 50 of 115 listed here. See the rest on GovTribe.
On GovTribe
Work with this file
- Download the original file
- Contacts named in this file
- Similar government files
- Ask GovTribe AI about this file
Text version
Clms Exc De-ID Dx PYTD-1
| CITY OF MIAMI | ||||||||||||
| DE-IDENTIFIED CLAIMS EXCEEDING REPORT | ||||||||||||
| EXHIBIT 39 | ||||||||||||
| January 2024 thru December 2024 | ||||||||||||
| Rating Type : POOLED STOP LOSS, RETROSPECTIVE EXPERIENCE RATED | ||||||||||||
| Claims Exceeding : $50,000.00 | ||||||||||||
| Reported Claims: InNet, OutNet, Drug | ||||||||||||
| Diagnosis is based on the largest medical claim amount | ||||||||||||
| BENEFIT OPTION | BRANCH | FUNDING TYPE | RATING TYPE | REL | GENDER | AGE BAND | ICD CODE | ICD DESCRIPTION | ICD VERSION | DRUG CLAIMS | PAID CLAIMS | CLAIMANT TOTAL |
| OAPAE-OAP PLAN ALL EMPLOYEES | NAGEN-ACTIVE EMPLOYEES (GENERAL) | 2 | R | SP | M | 50-59 | M79671 | PAIN IN RIGHT FOOT | 10 | $109,216 | $1,756 | $110,972 |
| OAPAE-OAP PLAN ALL EMPLOYEES | NAGEN-ACTIVE EMPLOYEES (GENERAL) | 2 | R | SP | F | 30-39 | K3530 | ACUTE APPENDICITIS WITH LOC PERITONITIS, W/O PERF OR GANGR | 10 | $45,921 | $14,168 | $60,089 |
| NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES) | NAGEN-ACTIVE EMPLOYEES (GENERAL) | 2 | R | SP | F | 50-59 | E042 | NONTOXIC MULTINODULAR GOITER | 10 | $2 | $107 | $109 |
| OAPAE-OAP PLAN ALL EMPLOYEES | NAGEN-ACTIVE EMPLOYEES (GENERAL) | 2 | R | SP | F | 50-59 | E0500 | THYROTOXICOSIS W DIFFUSE GOITER W/O THYROTOXIC CRISIS | 10 | $1,388 | $192,467 | $193,855 |
| $1,389 | $192,574 | $193,964 | ||||||||||
| NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES) | NAGEN-ACTIVE EMPLOYEES (GENERAL) | 2 | R | EE | M | 50-59 | C61 | MALIGNANT NEOPLASM OF PROSTATE | 10 | $0 | $16,146 | $16,146 |
| OAPAE-OAP PLAN ALL EMPLOYEES | NAGEN-ACTIVE EMPLOYEES (GENERAL) | 2 | R | EE | M | 50-59 | C61 | MALIGNANT NEOPLASM OF PROSTATE | 10 | $0 | $167,807 | $167,807 |
| $0 | $183,953 | $183,953 | ||||||||||
| NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES) | NASEA-ACTIVE EMPLOYEES (SEA) | 2 | R | EE | M | 50-59 | N186 | END STAGE RENAL DISEASE | 10 | $0 | $14,891 | $14,891 |
| OAPAE-OAP PLAN ALL EMPLOYEES | NASEA-ACTIVE EMPLOYEES (SEA) | 2 | R | EE | M | 50-59 | N186 | END STAGE RENAL DISEASE | 10 | $21,744 | $113,977 | $135,721 |
| $21,744 | $128,868 | $150,613 | ||||||||||
| NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES) | NAGEN-ACTIVE EMPLOYEES (GENERAL) | 2 | R | EE | M | 65+ | Z0000 | ENCNTR FOR GENERAL ADULT MEDICAL EXAM W/O ABNORMAL FINDINGS | 10 | $0 | ($67) | ($67) |
| OAPAE-OAP PLAN ALL EMPLOYEES | NAGEN-ACTIVE EMPLOYEES (GENERAL) | 2 | R | EE | M | 65+ | I25110 | ATHSCL HEART DISEASE OF NATIVE COR ART W UNSTABLE ANG PCTRS | 10 | $1,707 | $81,713 | $83,420 |
| $1,707 | $81,646 | $83,353 | ||||||||||
| OAPAE-OAP PLAN ALL EMPLOYEES | NAMC-ACTIVE EMPLOYEES (M/C) | 2 | R | EE | F | 50-59 | N2889 | OTHER SPECIFIED DISORDERS OF KIDNEY AND URETER | 10 | $3,784 | $84,397 | $88,180 |
| NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES) | E1211-EXECUTIVES/ELECTED OFFICIALS | 2 | R | EE | M | 65+ | D61810 | ANTINEOPLASTIC CHEMOTHERAPY INDUCED PANCYTOPENIA | 10 | $43 | $31,747 | $31,790 |
| OAPAE-OAP PLAN ALL EMPLOYEES | E1211-EXECUTIVES/ELECTED OFFICIALS | 1 | M | EE | M | 65+ | * | UNSPECIFIED | * | $0 | $98,994 | $98,994 |
| OAPAE-OAP PLAN ALL EMPLOYEES | E1211-EXECUTIVES/ELECTED OFFICIALS | 2 | R | EE | M | 65+ | Z5111 | ENCOUNTER FOR ANTINEOPLASTIC CHEMOTHERAPY | 10 | $109,557 | $208,590 | $318,147 |
| $109,600 | $339,331 | $448,931 | ||||||||||
| NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES) | E1211-EXECUTIVES/ELECTED OFFICIALS | 2 | R | CH | F | 1-17 | L209 | ATOPIC DERMATITIS, UNSPECIFIED | 10 | $0 | $21 | $21 |
| OAPAE-OAP PLAN ALL EMPLOYEES | E1211-EXECUTIVES/ELECTED OFFICIALS | 2 | R | CH | F | 1-17 | R1031 | RIGHT LOWER QUADRANT PAIN | 10 | $54,596 | $3,851 | $58,447 |
| $54,596 | $3,872 | $58,468 | ||||||||||
| OAPAE-OAP PLAN ALL EMPLOYEES | NASEA-ACTIVE EMPLOYEES (SEA) | 2 | R | EE | M | 60-64 | C3490 | MALIGNANT NEOPLASM OF UNSP PART OF UNSP BRONCHUS OR LUNG | 10 | $1,110 | $207,788 | $208,897 |
| NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES) | NAGEN-ACTIVE EMPLOYEES (GENERAL) | 2 | R | EE | M | 30-39 | PH | PHARMACY | * | $19,642 | $0 | $19,642 |
| OAPAE-OAP PLAN ALL EMPLOYEES | NAGEN-ACTIVE EMPLOYEES (GENERAL) | 2 | R | EE | M | 30-39 | H33323 | ROUND HOLE, BILATERAL | 10 | $87,873 | $2,161 | $90,034 |
| $107,515 | $2,161 | $109,676 | ||||||||||
| NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES) | E1211-EXECUTIVES/ELECTED OFFICIALS | 1 | M | EE | F | 40-49 | * | UNSPECIFIED | * | $0 | $310,505 | $310,505 |
| NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES) | E1211-EXECUTIVES/ELECTED OFFICIALS | 2 | R | EE | F | 40-49 | C9200 | ACUTE MYELOBLASTIC LEUKEMIA, NOT HAVING ACHIEVED REMISSION | 10 | $0 | $300,967 | $300,967 |
| OAPAE-OAP PLAN ALL EMPLOYEES | E1211-EXECUTIVES/ELECTED OFFICIALS | 1 | M | EE | F | 40-49 | * | UNSPECIFIED | * | $0 | $216,751 | $216,751 |
| OAPAE-OAP PLAN ALL EMPLOYEES | E1211-EXECUTIVES/ELECTED OFFICIALS | 2 | R | EE | F | 40-49 | S065XAA | TRAUM SUBDR HEM WITH LOC STATUS UNKNOWN, INITIAL ENCOUNTER | 10 | $26 | $48,869 | $48,894 |
| $26 | $877,092 | $877,118 | ||||||||||
| OAPAE-OAP PLAN ALL EMPLOYEES | NAGEN-ACTIVE EMPLOYEES (GENERAL) | 2 | R | EE | M | 65+ | Z23 | ENCOUNTER FOR IMMUNIZATION | 10 | $52,756 | $1,858 | $54,614 |
| OAPAE-OAP PLAN ALL EMPLOYEES | NAGEN-ACTIVE EMPLOYEES (GENERAL) | 2 | R | CH | M | 1-17 | M65861 | OTHER SYNOVITIS AND TENOSYNOVITIS, RIGHT LOWER LEG | 10 | $58,156 | $10,754 | $68,910 |
| NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES) | E1211-EXECUTIVES/ELECTED OFFICIALS | 2 | R | SP | F | 50-59 | PH | PHARMACY | * | $26,967 | $0 | $26,967 |
| NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES) | E1211-EXECUTIVES/ELECTED OFFICIALS | 2 | R | SP | F | 60-64 | Z0000 | ENCNTR FOR GENERAL ADULT MEDICAL EXAM W/O ABNORMAL FINDINGS | 10 | $1 | $142 | $143 |
| OAPAE-OAP PLAN ALL EMPLOYEES | E1211-EXECUTIVES/ELECTED OFFICIALS | 2 | R | SP | F | 60-64 | Z1211 | ENCOUNTER FOR SCREENING FOR MALIGNANT NEOPLASM OF COLON | 10 | $176,240 | $5,580 | $181,820 |
| $203,208 | $5,722 | $208,930 | ||||||||||
| NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES) | NAGEN-ACTIVE EMPLOYEES (GENERAL) | 2 | R | SP | F | 40-49 | PH | PHARMACY | * | $19,214 | $0 | $19,214 |
| OAPAE-OAP PLAN ALL EMPLOYEES | NAGEN-ACTIVE EMPLOYEES (GENERAL) | 2 | R | SP | F | 40-49 | Z01419 | ENCNTR FOR GYN EXAM (GENERAL) (ROUTINE) W/O ABN FINDINGS | 10 | $81,351 | $1,790 | $83,142 |
| $100,565 | $1,790 | $102,355 | ||||||||||
| NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES) | NAGEN-ACTIVE EMPLOYEES (GENERAL) | 2 | R | SP | F | 60-64 | D123 | BENIGN NEOPLASM OF TRANSVERSE COLON | 10 | $0 | $537 | $537 |
| OAPAE-OAP PLAN ALL EMPLOYEES | NAGEN-ACTIVE EMPLOYEES (GENERAL) | 2 | R | SP | F | 60-64 | L732 | HIDRADENITIS SUPPURATIVA | 10 | $59,368 | $3,412 | $62,780 |
| $59,368 | $3,950 | $63,318 | ||||||||||
| NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES) | NAGEN-ACTIVE EMPLOYEES (GENERAL) | 2 | R | EE | M | 18-29 | PH | PHARMACY | * | $19 | $0 | $19 |
| OAPAE-OAP PLAN ALL EMPLOYEES | NAGEN-ACTIVE EMPLOYEES (GENERAL) | 2 | R | EE | M | 18-29 | D619 | APLASTIC ANEMIA, UNSPECIFIED | 10 | $84,574 | $3,847 | $88,421 |
| $84,593 | $3,847 | $88,441 | ||||||||||
| NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES) | NAGEN-ACTIVE EMPLOYEES (GENERAL) | 2 | R | SP | M | 65+ | C9210 | CHRONIC MYELOID LEUK, BCR/ABL-POSITIVE, NOT ACHIEVE REMIS | 10 | $0 | $211 | $211 |
| OAPAE-OAP PLAN ALL EMPLOYEES | NAGEN-ACTIVE EMPLOYEES (GENERAL) | 2 | R | SP | M | 65+ | K226 | GASTRO-ESOPHAGEAL LACERATION-HEMORRHAGE SYNDROME | 10 | $21,815 | $113,950 | $135,765 |
| $21,815 | $114,161 | $135,976 | ||||||||||
| NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES) | NAGEN-ACTIVE EMPLOYEES (GENERAL) | 2 | R | EE | F | 40-49 | Z1379 | ENCNTR FOR OTH SCREENING FOR GENETIC AND CHROMSOML ANOMALIES | 10 | $0 | $2,566 | $2,566 |
| OAPAE-OAP PLAN ALL EMPLOYEES | NAGEN-ACTIVE EMPLOYEES (GENERAL) | 2 | R | EE | F | 40-49 | C50912 | MALIGNANT NEOPLASM OF UNSPECIFIED SITE OF LEFT FEMALE BREAST | 10 | $135,627 | $105,451 | $241,078 |
| $135,627 | $108,018 | $243,645 | ||||||||||
| OAPAE-OAP PLAN ALL EMPLOYEES | NAGEN-ACTIVE EMPLOYEES (GENERAL) | 2 | R | SP | F | 50-59 | D320 | BENIGN NEOPLASM OF CEREBRAL MENINGES | 10 | $3,288 | $77,206 | $80,494 |
| NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES) | NAGEN-ACTIVE EMPLOYEES (GENERAL) | 2 | R | EE | M | 50-59 | Z7984 | LONG TERM (CURRENT) USE OF ORAL HYPOGLYCEMIC DRUGS | 10 | $0 | $25 | $25 |
| NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES) | NAGEN-ACTIVE EMPLOYEES (GENERAL) | 2 | R | EE | M | 60-64 | K9189 | OTH POSTPROCEDURAL COMPLICATIONS AND DISORDERS OF DGSTV SYS | 10 | $0 | $158,468 | $158,468 |
| OAPAE-OAP PLAN ALL EMPLOYEES | NAGEN-ACTIVE EMPLOYEES (GENERAL) | 2 | R | EE | M | 60-64 | S43101A | UNSP DISLOCATION OF RIGHT ACROMIOCLAVICULAR JOINT, INIT | 10 | $27,073 | $12,438 | $39,511 |
| $27,073 | $170,931 | $198,004 | ||||||||||
| OAPAE-OAP PLAN ALL EMPLOYEES | NASEA-ACTIVE EMPLOYEES (SEA) | 2 | R | EE | F | 50-59 | I2111 | STEMI INVOLVING RIGHT CORONARY ARTERY | 10 | $8,567 | $78,906 | $87,473 |
| NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES) | NAGEN-ACTIVE EMPLOYEES (GENERAL) | 2 | R | EE | M | 30-39 | L0100 | IMPETIGO, UNSPECIFIED | 10 | $0 | $49 | $49 |
| OAPAE-OAP PLAN ALL EMPLOYEES | NAGEN-ACTIVE EMPLOYEES (GENERAL) | 2 | R | EE | M | 30-39 | K612 | ANORECTAL ABSCESS | 10 | $26,759 | $44,476 | $71,236 |
| $26,759 | $44,526 | $71,285 | ||||||||||
| OAPAE-OAP PLAN ALL EMPLOYEES | NAMC-ACTIVE EMPLOYEES (M/C) | 2 | R | EE | M | 40-49 | G610 | GUILLAIN-BARRE SYNDROME | 10 | $33,922 | $59,275 | $93,197 |
| OAPAE-OAP PLAN ALL EMPLOYEES | NAMC-ACTIVE EMPLOYEES (M/C) | 2 | R | CH | M | 1-17 | G4489 | OTHER HEADACHE SYNDROME | 10 | $136,493 | $36,992 | $173,485 |
| NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES) | NAMC-ACTIVE EMPLOYEES (M/C) | 2 | R | SP | F | 50-59 | K2970 | GASTRITIS, UNSPECIFIED, WITHOUT BLEEDING | 10 | $70 | $1,114 | $1,183 |
| OAPAE-OAP PLAN ALL EMPLOYEES | NAMC-ACTIVE EMPLOYEES (M/C) | 2 | R | SP | F | 50-59 | R1900 | INTRA-ABD AND PELVIC SWELLING, MASS AND LUMP, UNSP SITE | 10 | $8,021 | $71,614 | $79,635 |
| $8,091 | $72,728 | $80,819 | ||||||||||
| NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES) | NAGEN-ACTIVE EMPLOYEES (GENERAL) | 2 | R | EE | M | 50-59 | H209 | UNSPECIFIED IRIDOCYCLITIS | 10 | $0 | ($103) | ($103) |
| NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES) | NAGEN-ACTIVE EMPLOYEES (GENERAL) | 2 | R | EE | M | 60-64 | M25512 | PAIN IN LEFT SHOULDER | 10 | $19 | $91 | $111 |
| OAPAE-OAP PLAN ALL EMPLOYEES | NAGEN-ACTIVE EMPLOYEES (GENERAL) | 2 | R | EE | M | 60-64 | C61 | MALIGNANT NEOPLASM OF PROSTATE | 10 | $32,944 | $47,544 | $80,487 |
| $32,963 | $47,532 | $80,495 | ||||||||||
| OAPAE-OAP PLAN ALL EMPLOYEES | NAGEN-ACTIVE EMPLOYEES (GENERAL) | 2 | R | CH | M | <-1 | Z3800 | SINGLE LIVEBORN INFANT, DELIVERED VAGINALLY | 10 | $0 | $66,123 | $66,123 |
| NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES) | NAGEN-ACTIVE EMPLOYEES (GENERAL) | 2 | R | EE | M | 50-59 | G20 | PARKINSON'S DISEASE | 10 | $20,561 | $194 | $20,755 |
| OAPAE-OAP PLAN ALL EMPLOYEES | NAGEN-ACTIVE EMPLOYEES (GENERAL) | 2 | R | EE | M | 50-59 | I119 | HYPERTENSIVE HEART DISEASE WITHOUT HEART FAILURE | 10 | $101,079 | $4,182 | $105,261 |
| OAPAE-OAP PLAN ALL EMPLOYEES | NAGEN-ACTIVE EMPLOYEES (GENERAL) | 2 | R | EE | M | 60-64 | K2950 | UNSPECIFIED CHRONIC GASTRITIS WITHOUT BLEEDING | 10 | $22,276 | $2,349 | $24,625 |
| $143,917 | $6,724 | $150,641 | ||||||||||
| NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES) | NAGEN-ACTIVE EMPLOYEES (GENERAL) | 2 | R | EE | F | 65+ | I4821 | PERMANENT ATRIAL FIBRILLATION | 10 | $0 | $80 | $80 |
| OAPAE-OAP PLAN ALL EMPLOYEES | NAGEN-ACTIVE EMPLOYEES (GENERAL) | 2 | R | EE | F | 65+ | J180 | BRONCHOPNEUMONIA, UNSPECIFIED ORGANISM | 10 | $49,449 | $3,766 | $53,215 |
| OAPAE-OAP PLAN ALL EMPLOYEES | NRETG1-NON-MEDICARE RETIREE - 65 W/ DEP - 65 | 2 | R | EE | F | 65+ | I110 | HYPERTENSIVE HEART DISEASE WITH HEART FAILURE | 10 | $141,687 | $3,087 | $144,775 |
| $191,137 | $6,933 | $198,070 | ||||||||||
| NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES) | NAGEN-ACTIVE EMPLOYEES (GENERAL) | 2 | R | EE | F | 50-59 | Z5111 | ENCOUNTER FOR ANTINEOPLASTIC CHEMOTHERAPY | 10 | $0 | $1,014 | $1,014 |
| OAPAE-OAP PLAN ALL EMPLOYEES | NAGEN-ACTIVE EMPLOYEES (GENERAL) | 1 | M | EE | F | 50-59 | * | UNSPECIFIED | * | $0 | $157,789 | $157,789 |
| OAPAE-OAP PLAN ALL EMPLOYEES | NAGEN-ACTIVE EMPLOYEES (GENERAL) | 2 | R | EE | F | 50-59 | Z5112 | ENCOUNTER FOR ANTINEOPLASTIC IMMUNOTHERAPY | 10 | $0 | $348,610 | $348,610 |
| $0 | $507,413 | $507,413 | ||||||||||
| NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES) | NASEA-ACTIVE EMPLOYEES (SEA) | 2 | R | EE | M | 60-64 | PH | PHARMACY | * | ($57) | $0 | ($57) |
| OAPAE-OAP PLAN ALL EMPLOYEES | NASEA-ACTIVE EMPLOYEES (SEA) | 2 | R | EE | M | 60-64 | I4719 | OTHER SUPRAVENTRICULAR TACHYCARDIA | 10 | $5,065 | $68,760 | $73,825 |
| OAPAE-OAP PLAN ALL EMPLOYEES | NRSEA1-NON-MEDICARE RETIREE - 65 W/ DEP - 65 | 2 | R | EE | M | 60-64 | Z01818 | ENCOUNTER FOR OTHER PREPROCEDURAL EXAMINATION | 10 | $2,475 | $367 | $2,842 |
| $7,483 | $69,127 | $76,610 | ||||||||||
| NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES) | NAGEN-ACTIVE EMPLOYEES (GENERAL) | 2 | R | EE | M | 50-59 | C155 | MALIGNANT NEOPLASM OF LOWER THIRD OF ESOPHAGUS | 10 | $0 | ($5,239) | ($5,239) |
| NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES) | NAGEN-ACTIVE EMPLOYEES (GENERAL) | 2 | R | EE | M | 60-64 | C159 | MALIGNANT NEOPLASM OF ESOPHAGUS, UNSPECIFIED | 10 | $12 | $80,405 | $80,417 |
| OAPAE-OAP PLAN ALL EMPLOYEES | NAGEN-ACTIVE EMPLOYEES (GENERAL) | 2 | R | EE | M | 60-64 | Z5112 | ENCOUNTER FOR ANTINEOPLASTIC IMMUNOTHERAPY | 10 | $3,304 | $266,340 | $269,644 |
| $3,316 | $341,506 | $344,822 | ||||||||||
| NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES) | NASEA-ACTIVE EMPLOYEES (SEA) | 2 | R | EE | M | 50-59 | C20 | MALIGNANT NEOPLASM OF RECTUM | 10 | $10 | $3,335 | $3,345 |
| OAPAE-OAP PLAN ALL EMPLOYEES | NASEA-ACTIVE EMPLOYEES (SEA) | 2 | R | EE | M | 50-59 | C20 | MALIGNANT NEOPLASM OF RECTUM | 10 | $405 | $91,771 | $92,177 |
| $415 | $95,107 | $95,521 | ||||||||||
| NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES) | NAGEN-ACTIVE EMPLOYEES (GENERAL) | 2 | R | EE | F | 65+ | M0579 | RHEU ARTHRITIS W RHEU FACTOR MULT SITE W/O ORG/SYS INVOLV | 10 | $0 | $103 | $103 |
| OAPAE-OAP PLAN ALL EMPLOYEES | NAGEN-ACTIVE EMPLOYEES (GENERAL) | 2 | R | EE | F | 65+ | N760 | ACUTE VAGINITIS | 10 | $67,431 | $1,938 | $69,369 |
| $67,431 | $2,041 | $69,472 | ||||||||||
| NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES) | NAGEN-ACTIVE EMPLOYEES (GENERAL) | 2 | R | EE | F | 30-39 | PH | PHARMACY | * | $15 | $0 | $15 |
| OAPAE-OAP PLAN ALL EMPLOYEES | NAGEN-ACTIVE EMPLOYEES (GENERAL) | 2 | R | EE | F | 30-39 | E6601 | MORBID (SEVERE) OBESITY DUE TO EXCESS CALORIES | 10 | $136 | $50,391 | $50,527 |
| $151 | $50,391 | $50,542 | ||||||||||
| NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES) | NASEA-ACTIVE EMPLOYEES (SEA) | 2 | R | EE | M | 65+ | S51812A | LACERATION WITHOUT FOREIGN BODY OF LEFT FOREARM, INIT ENCNTR | 10 | $7 | $142 | $150 |
| OAPAE-OAP PLAN ALL EMPLOYEES | NASEA-ACTIVE EMPLOYEES (SEA) | 2 | R | EE | M | 65+ | D62 | ACUTE POSTHEMORRHAGIC ANEMIA | 10 | $954 | $60,562 | $61,516 |
| $961 | $60,704 | $61,665 | ||||||||||
| NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES) | NASEA-ACTIVE EMPLOYEES (SEA) | 2 | R | EE | M | 30-39 | I161 | HYPERTENSIVE EMERGENCY | 10 | $0 | $1,896 | $1,896 |
| OAPAE-OAP PLAN ALL EMPLOYEES | NASEA-ACTIVE EMPLOYEES (SEA) | 2 | R | EE | M | 30-39 | I214 | NON-ST ELEVATION (NSTEMI) MYOCARDIAL INFARCTION | 10 | $10,268 | $98,268 | $108,535 |
| $10,268 | $100,164 | $110,432 | ||||||||||
| OAPAE-OAP PLAN ALL EMPLOYEES | NAMC-ACTIVE EMPLOYEES (M/C) | 2 | R | CH | F | 18-29 | N83202 | UNSPECIFIED OVARIAN CYST, LEFT SIDE | 10 | $44,357 | $7,819 | $52,176 |
| NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES) | NRETG1-NON-MEDICARE RETIREE - 65 W/ DEP - 65 | 2 | R | EE | M | 50-59 | E6601 | MORBID (SEVERE) OBESITY DUE TO EXCESS CALORIES | 10 | $11,201 | $53 | $11,254 |
| OAPAE-OAP PLAN ALL EMPLOYEES | NRETG1-NON-MEDICARE RETIREE - 65 W/ DEP - 65 | 2 | R | EE | M | 50-59 | G4733 | OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) | 10 | $79,082 | $3,109 | $82,191 |
| $90,283 | $3,162 | $93,445 | ||||||||||
| OAPAE-OAP PLAN ALL EMPLOYEES | NAGEN-ACTIVE EMPLOYEES (GENERAL) | 2 | R | EE | M | 50-59 | M25471 | EFFUSION, RIGHT ANKLE | 10 | $23,905 | $1,026 | $24,931 |
| OAPAE-OAP PLAN ALL EMPLOYEES | NAGEN-ACTIVE EMPLOYEES (GENERAL) | 2 | R | EE | M | 60-64 | I872 | VENOUS INSUFFICIENCY (CHRONIC) (PERIPHERAL) | 10 | $23,312 | $10,465 | $33,777 |
| $47,217 | $11,491 | $58,708 | ||||||||||
| NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES) | NAGEN-ACTIVE EMPLOYEES (GENERAL) | 1 | M | CH | F | 18-29 | * | UNSPECIFIED | * | $0 | ($526) | ($526) |
| NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES) | NAGEN-ACTIVE EMPLOYEES (GENERAL) | 2 | R | CH | F | 18-29 | Z949 | TRANSPLANTED ORGAN AND TISSUE STATUS, UNSPECIFIED | 10 | ($329) | $14,286 | $13,957 |
| OAPAE-OAP PLAN ALL EMPLOYEES | NAGEN-ACTIVE EMPLOYEES (GENERAL) | 2 | R | CH | F | 18-29 | M87852 | OTHER OSTEONECROSIS, LEFT FEMUR | 10 | $14,943 | $107,423 | $122,367 |
| $14,614 | $121,183 | $135,797 | ||||||||||
| NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES) | NAGEN-ACTIVE EMPLOYEES (GENERAL) | 2 | R | EE | F | 50-59 | C50812 | MALIGNANT NEOPLASM OF OVRLP SITES OF LEFT FEMALE BREAST | 10 | $0 | $26,499 | $26,499 |
| OAPAE-OAP PLAN ALL EMPLOYEES | NAGEN-ACTIVE EMPLOYEES (GENERAL) | 2 | R | EE | F | 50-59 | C50812 | MALIGNANT NEOPLASM OF OVRLP SITES OF LEFT FEMALE BREAST | 10 | $202,210 | $110,550 | $312,760 |
| $202,210 | $137,049 | $339,259 | ||||||||||
| NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES) | NAGEN-ACTIVE EMPLOYEES (GENERAL) | 2 | R | EE | M | 50-59 | N419 | INFLAMMATORY DISEASE OF PROSTATE, UNSPECIFIED | 10 | $0 | $11 | $11 |
| NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES) | NAGEN-ACTIVE EMPLOYEES (GENERAL) | 2 | R | EE | M | 60-64 | R9720 | ELEVATED PROSTATE SPECIFIC ANTIGEN [PSA] | 10 | $58 | $15 | $73 |
| OAPAE-OAP PLAN ALL EMPLOYEES | NAGEN-ACTIVE EMPLOYEES (GENERAL) | 2 | R | EE | M | 60-64 | I330 | ACUTE AND SUBACUTE INFECTIVE ENDOCARDITIS | 10 | $14,332 | $242,330 | $256,663 |
| $14,390 | $242,357 | $256,747 | ||||||||||
| NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES) | NAGEN-ACTIVE EMPLOYEES (GENERAL) | 2 | R | EE | F | 40-49 | Z0001 | ENCOUNTER FOR GENERAL ADULT MEDICAL EXAM W ABNORMAL FINDINGS | 10 | $55 | $88 | $143 |
| OAPAE-OAP PLAN ALL EMPLOYEES | NAGEN-ACTIVE EMPLOYEES (GENERAL) | 2 | R | EE | F | 40-49 | D0512 | INTRADUCTAL CARCINOMA IN SITU OF LEFT BREAST | 10 | $365 | $127,793 | $128,158 |
| $420 | $127,881 | $128,301 | ||||||||||
| NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES) | NAGEN-ACTIVE EMPLOYEES (GENERAL) | 2 | R | EE | M | 40-49 | K50118 | CROHN'S DISEASE OF LARGE INTESTINE WITH OTHER COMPLICATION | 10 | $0 | $455 | $455 |
| OAPAE-OAP PLAN ALL EMPLOYEES | NAGEN-ACTIVE EMPLOYEES (GENERAL) | 2 | R | EE | M | 40-49 | K50118 | CROHN'S DISEASE OF LARGE INTESTINE WITH OTHER COMPLICATION | 10 | $41 | $108,399 | $108,439 |
| $41 | $108,853 | $108,894 | ||||||||||
| NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES) | NAMC-ACTIVE EMPLOYEES (M/C) | 2 | R | EE | F | 40-49 | O09513 | SUPERVISION OF ELDERLY PRIMIGRAVIDA, THIRD TRIMESTER | 10 | $0 | $452 | $452 |
| OAPAE-OAP PLAN ALL EMPLOYEES | NAMC-ACTIVE EMPLOYEES (M/C) | 2 | R | EE | F | 40-49 | O85 | PUERPERAL SEPSIS | 10 | $1,436 | $75,984 | $77,420 |
| $1,436 | $76,436 | $77,872 | ||||||||||
| NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES) | NAGEN-ACTIVE EMPLOYEES (GENERAL) | 2 | R | EE | M | 30-39 | G129 | SPINAL MUSCULAR ATROPHY, UNSPECIFIED | 10 | $0 | $16,640 | $16,640 |
| OAPAE-OAP PLAN ALL EMPLOYEES | NAGEN-ACTIVE EMPLOYEES (GENERAL) | 2 | R | EE | M | 30-39 | G129 | SPINAL MUSCULAR ATROPHY, UNSPECIFIED | 10 | $0 | $9,984 | $9,984 |
| OAPAE-OAP PLAN ALL EMPLOYEES | NAGEN-ACTIVE EMPLOYEES (GENERAL) | 2 | R | EE | M | 40-49 | G129 | SPINAL MUSCULAR ATROPHY, UNSPECIFIED | 10 | $0 | $60,868 | $60,868 |
| $0 | $87,492 | $87,492 | ||||||||||
| NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES) | E1211-EXECUTIVES/ELECTED OFFICIALS | 2 | R | EE | F | 40-49 | J101 | FLU DUE TO OTH IDENT INFLUENZA VIRUS W OTH RESP MANIFEST | 10 | $8 | $2,588 | $2,596 |
| OAPAE-OAP PLAN ALL EMPLOYEES | E1211-EXECUTIVES/ELECTED OFFICIALS | 2 | R | EE | F | 40-49 | T8611 | KIDNEY TRANSPLANT REJECTION | 10 | $17,964 | $128,424 | $146,388 |
| $17,971 | $131,012 | $148,984 | ||||||||||
| NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES) | NAGEN-ACTIVE EMPLOYEES (GENERAL) | 2 | R | SP | F | 50-59 | PH | PHARMACY | * | $27 | $0 | $27 |
| OAPAE-OAP PLAN ALL EMPLOYEES | NAGEN-ACTIVE EMPLOYEES (GENERAL) | 2 | R | SP | F | 50-59 | E0520 | THYROTXCOSIS W TOXIC MULTINOD GOITER W/O THYROTOXIC CRISIS | 10 | $12,220 | $38,858 | $51,078 |
| $12,248 | $38,858 | $51,106 | ||||||||||
| NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES) | NAGEN-ACTIVE EMPLOYEES (GENERAL) | 2 | R | EE | F | 30-39 | J069 | ACUTE UPPER RESPIRATORY INFECTION, UNSPECIFIED | 10 | $0 | $59 | $59 |
| OAPAE-OAP PLAN ALL EMPLOYEES | NAGEN-ACTIVE EMPLOYEES (GENERAL) | 2 | R | EE | F | 30-39 | B349 | VIRAL INFECTION, UNSPECIFIED | 10 | $47,044 | $8,172 | $55,216 |
| $47,044 | $8,231 | $55,275 | ||||||||||
| NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES) | NASEA-ACTIVE EMPLOYEES (SEA) | 2 | R | EE | M | 40-49 | F418 | OTHER SPECIFIED ANXIETY DISORDERS | 10 | $0 | $58 | $59 |
| OAPAE-OAP PLAN ALL EMPLOYEES | NASEA-ACTIVE EMPLOYEES (SEA) | 2 | R | EE | M | 40-49 | I71010 | DISSECTION OF ASCENDING AORTA | 10 | $12,951 | $55,927 | $68,878 |
| $12,951 | $55,986 | $68,937 | ||||||||||
| NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES) | NAGEN-ACTIVE EMPLOYEES (GENERAL) | 2 | R | SP | F | 50-59 | R102 | PELVIC AND PERINEAL PAIN | 10 | $7 | $514 | $521 |
| OAPAE-OAP PLAN ALL EMPLOYEES | NAGEN-ACTIVE EMPLOYEES (GENERAL) | 2 | R | SP | F | 50-59 | G35 | MULTIPLE SCLEROSIS | 10 | $54,616 | $21,551 | $76,166 |
| $54,623 | $22,065 | $76,687 | ||||||||||
| NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES) | NAGEN-ACTIVE EMPLOYEES (GENERAL) | 2 | R | EE | F | 40-49 | M542 | CERVICALGIA | 10 | $0 | $4,800 | $4,800 |
| OAPAE-OAP PLAN ALL EMPLOYEES | NAGEN-ACTIVE EMPLOYEES (GENERAL) | 2 | R | EE | F | 40-49 | R55 | SYNCOPE AND COLLAPSE | 10 | $12,672 | $41,064 | $53,737 |
| $12,672 | $45,864 | $58,537 | ||||||||||
| NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES) | NAGEN-ACTIVE EMPLOYEES (GENERAL) | 2 | R | EE | M | 65+ | A4101 | SEPSIS DUE TO METHICILLIN SUSCEPTIBLE STAPHYLOCOCCUS AUREUS | 10 | $6 | $14,686 | $14,692 |
| OAPAE-OAP PLAN ALL EMPLOYEES | NAGEN-ACTIVE EMPLOYEES (GENERAL) | 2 | R | EE | M | 65+ | I25111 | ATHSCL HEART DISEASE OF NATIVE COR ART W ANG PCTRS W SPASM | 10 | $134,118 | $10,876 | $144,993 |
| $134,124 | $25,562 | $159,686 | ||||||||||
| NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES) | NAGEN-ACTIVE EMPLOYEES (GENERAL) | 2 | R | EE | F | 40-49 | I671 | CEREBRAL ANEURYSM, NONRUPTURED | 10 | ($5) | $2,115 | $2,110 |
| OAPAE-OAP PLAN ALL EMPLOYEES | NAGEN-ACTIVE EMPLOYEES (GENERAL) | 2 | R | EE | F | 40-49 | R1012 | LEFT UPPER QUADRANT PAIN | 10 | $145,083 | $8,345 | $153,428 |
| $145,079 | $10,459 | $155,538 | ||||||||||
| NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES) | NAGEN-ACTIVE EMPLOYEES (GENERAL) | 2 | R | EE | F | 60-64 | D0511 | INTRADUCTAL CARCINOMA IN SITU OF RIGHT BREAST | 10 | $0 | $271 | $271 |
| OAPAE-OAP PLAN ALL EMPLOYEES | NAGEN-ACTIVE EMPLOYEES (GENERAL) | 2 | R | EE | F | 65+ | N6325 | UNSPECIFIED LUMP IN THE LEFT BREAST, OVERLAPPING QUADRANTS | 10 | $95,828 | $16,513 | $112,341 |
| $95,828 | $16,784 | $112,613 | ||||||||||
| NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES) | NAGEN-ACTIVE EMPLOYEES (GENERAL) | 2 | R | CH | M | <-1 | PH | PHARMACY | * | $82 | $0 | $82 |
| OAPAE-OAP PLAN ALL EMPLOYEES | NAGEN-ACTIVE EMPLOYEES (GENERAL) | 2 | R | CH | M | <-1 | Q338 | OTHER CONGENITAL MALFORMATIONS OF LUNG | 10 | $0 | $51,910 | $51,910 |
| OAPAE-OAP PLAN ALL EMPLOYEES | NAGEN-ACTIVE EMPLOYEES (GENERAL) | 2 | R | CH | M | 1-17 | Z00129 | ENCNTR FOR ROUTINE CHILD HEALTH EXAM W/O ABNORMAL FINDINGS | 10 | $0 | $645 | $645 |
| $82 | $52,555 | $52,637 | ||||||||||
| NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES) | NAGEN-ACTIVE EMPLOYEES (GENERAL) | 2 | R | EE | F | 40-49 | PH | PHARMACY | * | ($716) | $0 | ($716) |
| OAPAE-OAP PLAN ALL EMPLOYEES | NAGEN-ACTIVE EMPLOYEES (GENERAL) | 2 | R | EE | F | 40-49 | J069 | ACUTE UPPER RESPIRATORY INFECTION, UNSPECIFIED | 10 | $4,633 | $286 | $4,919 |
| OAPAE-OAP PLAN ALL EMPLOYEES | NAGEN-ACTIVE EMPLOYEES (GENERAL) | 2 | R | EE | F | 50-59 | M1711 | UNILATERAL PRIMARY OSTEOARTHRITIS, RIGHT KNEE | 10 | $17,184 | $49,291 | $66,476 |
| $21,102 | $49,578 | $70,679 | ||||||||||
| NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES) | NAGEN-ACTIVE EMPLOYEES (GENERAL) | 2 | R | EE | F | 30-39 | M50022 | CERVICAL DISC DISORDER AT C5-C6 LEVEL WITH MYELOPATHY | 10 | $0 | $57,197 | $57,197 |
| OAPAE-OAP PLAN ALL EMPLOYEES | NAGEN-ACTIVE EMPLOYEES (GENERAL) | 2 | R | EE | F | 30-39 | O480 | POST-TERM PREGNANCY | 10 | $40 | $40,755 | $40,795 |
| $40 | $97,952 | $97,992 | ||||||||||
| NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES) | NAGEN-ACTIVE EMPLOYEES (GENERAL) | 1 | M | EE | F | 50-59 | * | UNSPECIFIED | * | $0 | $49 | $49 |
| NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES) | NAGEN-ACTIVE EMPLOYEES (GENERAL) | 2 | R | EE | F | 50-59 | C9201 | ACUTE MYELOBLASTIC LEUKEMIA, IN REMISSION | 10 | ($560) | $285,539 | $284,979 |
| OAPAE-OAP PLAN ALL EMPLOYEES | NAGEN-ACTIVE EMPLOYEES (GENERAL) | 2 | R | EE | F | 50-59 | C9201 | ACUTE MYELOBLASTIC LEUKEMIA, IN REMISSION | 10 | $12,544 | $46,255 | $58,799 |
| $11,984 | $331,843 | $343,827 | ||||||||||
| NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES) | NAGEN-ACTIVE EMPLOYEES (GENERAL) | 2 | R | SP | M | 60-64 | PH | PHARMACY | * | $36 | $0 | $36 |
| OAPAE-OAP PLAN ALL EMPLOYEES | NAGEN-ACTIVE EMPLOYEES (GENERAL) | 2 | R | SP | M | 60-64 | M5126 | OTHER INTERVERTEBRAL DISC DISPLACEMENT, LUMBAR REGION | 10 | $65,671 | $1,834 | $67,504 |
| $65,707 | $1,834 | $67,540 | ||||||||||
| NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES) | NAGEN-ACTIVE EMPLOYEES (GENERAL) | 2 | R | SP | M | 50-59 | PH | PHARMACY | * | $19 | $0 | $19 |
| OAPAE-OAP PLAN ALL EMPLOYEES | NAGEN-ACTIVE EMPLOYEES (GENERAL) | 2 | R | SP | M | 50-59 | N202 | CALCULUS OF KIDNEY WITH CALCULUS OF URETER | 10 | $7,851 | $51,164 | $59,015 |
| $7,870 | $51,164 | $59,034 | ||||||||||
| NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES) | NAGEN-ACTIVE EMPLOYEES (GENERAL) | 2 | R | CH | M | 18-29 | G40822 | EPILEPTIC SPASMS, NOT INTRACTABLE, W/O STATUS EPILEPTICUS | 10 | $135 | $616 | $751 |
| OAPAE-OAP PLAN ALL EMPLOYEES | NAGEN-ACTIVE EMPLOYEES (GENERAL) | 2 | R | CH | M | 18-29 | G40909 | EPILEPSY, UNSP, NOT INTRACTABLE, WITHOUT STATUS EPILEPTICUS | 10 | $45,444 | $4,399 | $49,843 |
| $45,579 | $5,015 | $50,594 | ||||||||||
| NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES) | NAGEN-ACTIVE EMPLOYEES (GENERAL) | 2 | R | SP | F | 30-39 | R102 | PELVIC AND PERINEAL PAIN | 10 | $0 | $216 | $216 |
| OAPAE-OAP PLAN ALL EMPLOYEES | NAGEN-ACTIVE EMPLOYEES (GENERAL) | 2 | R | SP | F | 30-39 | K2900 | ACUTE GASTRITIS WITHOUT BLEEDING | 10 | $12 | $60,218 | $60,230 |
| $12 | $60,433 | $60,446 | ||||||||||
| NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES) | NAGEN-ACTIVE EMPLOYEES (GENERAL) | 2 | R | CH | F | 18-29 | D485 | NEOPLASM OF UNCERTAIN BEHAVIOR OF SKIN | 10 | ($288) | $225 | ($63) |
| OAPAE-OAP PLAN ALL EMPLOYEES | NAGEN-ACTIVE EMPLOYEES (GENERAL) | 2 | R | CH | F | 18-29 | M352 | BEHCET'S DISEASE | 10 | $59,942 | $7,560 | $67,502 |
| $59,654 | $7,786 | $67,440 | ||||||||||
| NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES) | NAGEN-ACTIVE EMPLOYEES (GENERAL) | 2 | R | EE | M | 65+ | D735 | INFARCTION OF SPLEEN | 10 | $0 | $3,706 | $3,706 |
| NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES) | NRETG1-NON-MEDICARE RETIREE - 65 W/ DEP - 65 | 2 | R | EE | M | 65+ | G5621 | LESION OF ULNAR NERVE, RIGHT UPPER LIMB | 10 | $41 | $10,945 | $10,987 |
| OAPAE-OAP PLAN ALL EMPLOYEES | NRETG1-NON-MEDICARE RETIREE - 65 W/ DEP - 65 | 2 | R | EE | M | 65+ | I2510 | ATHSCL HEART DISEASE OF NATIVE CORONARY ARTERY W/O ANG PCTRS | 10 | $17,393 | $20,058 | $37,451 |
| $17,434 | $34,709 | $52,143 | ||||||||||
| OAPAE-OAP PLAN ALL EMPLOYEES | E1211-EXECUTIVES/ELECTED OFFICIALS | 2 | R | CH | F | <-1 | Z3801 | SINGLE LIVEBORN INFANT, DELIVERED BY CESAREAN | 10 | $608 | $218,144 | $218,752 |
| OAPAE-OAP PLAN ALL EMPLOYEES | E1211-EXECUTIVES/ELECTED OFFICIALS | 2 | R | CH | M | <-1 | PH | PHARMACY | * | $2 | $0 | $2 |
| $610 | $218,144 | $218,754 | ||||||||||
| OAPAE-OAP PLAN ALL EMPLOYEES | NAGEN-ACTIVE EMPLOYEES (GENERAL) | 2 | R | CH | M | 18-29 | J029 | ACUTE PHARYNGITIS, UNSPECIFIED | 10 | $42,518 | $290 | $42,808 |
| OAPAE-OAP PLAN ALL EMPLOYEES | NRETG1-NON-MEDICARE RETIREE - 65 W/ DEP - 65 | 2 | R | CH | M | 18-29 | K5080 | CROHN'S DISEASE OF BOTH SMALL AND LG INT W/O COMPLICATIONS | 10 | $24,818 | $661 | $25,479 |
| $67,336 | $950 | $68,286 | ||||||||||
| NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES) | NAGEN-ACTIVE EMPLOYEES (GENERAL) | 1 | M | EE | M | 60-64 | * | UNSPECIFIED | * | $0 | ($398) | ($398) |
| NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES) | NAGEN-ACTIVE EMPLOYEES (GENERAL) | 1 | M | EE | M | 65+ | * | UNSPECIFIED | * | $0 | $167 | $167 |
| NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES) | NAGEN-ACTIVE EMPLOYEES (GENERAL) | 2 | R | EE | M | 60-64 | M438X9 | OTHER SPECIFIED DEFORMING DORSOPATHIES, SITE UNSPECIFIED | 10 | $0 | $1,316 | $1,316 |
| NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES) | NAGEN-ACTIVE EMPLOYEES (GENERAL) | 2 | R | EE | M | 65+ | N179 | ACUTE KIDNEY FAILURE, UNSPECIFIED | 10 | $0 | $10,022 | $10,022 |
| OAPAE-OAP PLAN ALL EMPLOYEES | NAGEN-ACTIVE EMPLOYEES (GENERAL) | 2 | R | EE | M | 65+ | D693 | IMMUNE THROMBOCYTOPENIC PURPURA | 10 | $50 | $334,620 | $334,670 |
| $50 | $345,727 | $345,777 | ||||||||||
| NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES) | NASEA-ACTIVE EMPLOYEES (SEA) | 2 | R | EE | M | 60-64 | PH | PHARMACY | * | $13,859 | $0 | $13,859 |
| OAPAE-OAP PLAN ALL EMPLOYEES | NASEA-ACTIVE EMPLOYEES (SEA) | 2 | R | EE | M | 60-64 | C9110 | CHRONIC LYMPHOCYTIC LEUK OF B-CELL TYPE NOT ACHIEVE REMIS | 10 | $133,542 | $1,932 | $135,474 |
| $147,402 | $1,932 | $149,334 | ||||||||||
| NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES) | NAGEN-ACTIVE EMPLOYEES (GENERAL) | 2 | R | EE | M | 30-39 | M5450 | LOW BACK PAIN, UNSPECIFIED | 10 | $27,007 | $827 | $27,835 |
| OAPAE-OAP PLAN ALL EMPLOYEES | NAGEN-ACTIVE EMPLOYEES (GENERAL) | 1 | M | EE | M | 30-39 | * | UNSPECIFIED | * | $0 | $8,055 | $8,055 |
| OAPAE-OAP PLAN ALL EMPLOYEES | NAGEN-ACTIVE EMPLOYEES (GENERAL) | 2 | R | EE | M | 30-39 | J020 | STREPTOCOCCAL PHARYNGITIS | 10 | $320,588 | $1,576 | $322,164 |
| $347,595 | $10,459 | $358,054 | ||||||||||
| OAPAE-OAP PLAN ALL EMPLOYEES | NRETG1-NON-MEDICARE RETIREE - 65 W/ DEP - 65 | 2 | R | EE | F | 60-64 | T183XXA | FOREIGN BODY IN SMALL INTESTINE, INITIAL ENCOUNTER | 10 | $19,789 | $35,613 | $55,401 |
| NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES) | NAGEN-ACTIVE EMPLOYEES (GENERAL) | 2 | R | SP | M | 50-59 | M25461 | EFFUSION, RIGHT KNEE | 10 | $0 | $70 | $70 |
| OAPAE-OAP PLAN ALL EMPLOYEES | NAGEN-ACTIVE EMPLOYEES (GENERAL) | 2 | R | SP | M | 50-59 | H11441 | CONJUNCTIVAL CYSTS, RIGHT EYE | 10 | $37,430 | $23,284 | $60,714 |
| $37,430 | $23,354 | $60,784 | ||||||||||
| NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES) | NAGEN-ACTIVE EMPLOYEES (GENERAL) | 2 | R | SP | F | 40-49 | N6019 | DIFFUSE CYSTIC MASTOPATHY OF UNSPECIFIED BREAST | 10 | $0 | $57 | $57 |
| OAPAE-OAP PLAN ALL EMPLOYEES | NAGEN-ACTIVE EMPLOYEES (GENERAL) | 2 | R | SP | F | 40-49 | I2101 | STEMI INVOLVING LEFT MAIN CORONARY ARTERY | 10 | $1,897 | $259,430 | $261,327 |
| $1,897 | $259,487 | $261,384 | ||||||||||
| NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES) | NAGEN-ACTIVE EMPLOYEES (GENERAL) | 2 | R | EE | M | 40-49 | PH | PHARMACY | * | $3,354 | $0 | $3,354 |
| OAPAE-OAP PLAN ALL EMPLOYEES | NAGEN-ACTIVE EMPLOYEES (GENERAL) | 2 | R | EE | M | 40-49 | J351 | HYPERTROPHY OF TONSILS | 10 | $60,391 | $55,446 | $115,837 |
| $63,746 | $55,446 | $119,192 | ||||||||||
| NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES) | NAMC-ACTIVE EMPLOYEES (M/C) | 2 | R | EE | F | 50-59 | S12590A | OTH DISP FX OF SIXTH CERVICAL VERTEBRA, INIT FOR CLOS FX | 10 | $5 | $81,034 | $81,039 |
| OAPAE-OAP PLAN ALL EMPLOYEES | NAMC-ACTIVE EMPLOYEES (M/C) | 2 | R | EE | F | 50-59 | S32401D | UNSP FRACTURE OF RIGHT ACETABULUM, SUBS FOR FX W ROUTN HEAL | 10 | $11,040 | $82,339 | $93,379 |
| $11,046 | $163,372 | $174,418 | ||||||||||
| NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES) | NAGEN-ACTIVE EMPLOYEES (GENERAL) | 2 | R | EE | F | 40-49 | E113411 | TYPE 2 DIAB WITH SEVERE NONP RTNOP WITH MACULAR EDEMA, R EYE | 10 | $0 | $1,004 | $1,004 |
| OAPAE-OAP PLAN ALL EMPLOYEES | NAGEN-ACTIVE EMPLOYEES (GENERAL) | 2 | R | EE | F | 40-49 | L03116 | CELLULITIS OF LEFT LOWER LIMB | 10 | $27,519 | $22,775 | $50,294 |
| $27,519 | $23,780 | $51,299 | ||||||||||
| NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES) | NAGEN-ACTIVE EMPLOYEES (GENERAL) | 2 | R | SP | F | 40-49 | M7662 | ACHILLES TENDINITIS, LEFT LEG | 10 | $0 | $151 | $151 |
| OAPAE-OAP PLAN ALL EMPLOYEES | NAGEN-ACTIVE EMPLOYEES (GENERAL) | 2 | R | SP | F | 40-49 | R42 | DIZZINESS AND GIDDINESS | 10 | $61,020 | $31,576 | $92,596 |
| OAPAE-OAP PLAN ALL EMPLOYEES | NAGEN-ACTIVE EMPLOYEES (GENERAL) | 2 | R | SP | F | 50-59 | M459 | ANKYLOSING SPONDYLITIS OF UNSPECIFIED SITES IN SPINE | 10 | $74,316 | $16,640 | $90,956 |
| $135,336 | $48,367 | $183,703 | ||||||||||
| NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES) | NAGEN-ACTIVE EMPLOYEES (GENERAL) | 2 | R | EE | M | 60-64 | G4733 | OBSTRUCTIVE SLEEP APNEA (ADULT) (PEDIATRIC) | 10 | $0 | $289 | $289 |
| OAPAE-OAP PLAN ALL EMPLOYEES | NAGEN-ACTIVE EMPLOYEES (GENERAL) | 2 | R | EE | M | 60-64 | K8000 | CALCULUS OF GALLBLADDER W ACUTE CHOLECYST W/O OBSTRUCTION | 10 | $18,275 | $39,518 | $57,793 |
| $18,275 | $39,807 | $58,082 | ||||||||||
| OAPAE-OAP PLAN ALL EMPLOYEES | NAGEN-ACTIVE EMPLOYEES (GENERAL) | 2 | R | EE | F | 40-49 | G35 | MULTIPLE SCLEROSIS | 10 | $109,234 | $135 | $109,369 |
| OAPAE-OAP PLAN ALL EMPLOYEES | NAGEN-ACTIVE EMPLOYEES (GENERAL) | 2 | R | CH | F | <-1 | G40801 | OTHER EPILEPSY, NOT INTRACTABLE, WITH STATUS EPILEPTICUS | 10 | $0 | $39,726 | $39,726 |
| OAPAE-OAP PLAN ALL EMPLOYEES | NAGEN-ACTIVE EMPLOYEES (GENERAL) | 2 | R | CH | F | 1-17 | G40901 | EPILEPSY, UNSP, NOT INTRACTABLE, WITH STATUS EPILEPTICUS | 10 | $243 | $48,621 | $48,864 |
| $243 | $88,347 | $88,590 | ||||||||||
| OAPAE-OAP PLAN ALL EMPLOYEES | NAGEN-ACTIVE EMPLOYEES (GENERAL) | 2 | R | EE | M | 50-59 | S82841A | DISPLACED BIMALLEOLAR FRACTURE OF RIGHT LOWER LEG, INIT | 10 | $528 | $52,976 | $53,503 |
| NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES) | E1211-EXECUTIVES/ELECTED OFFICIALS | 2 | R | CH | M | 1-17 | J9383 | OTHER PNEUMOTHORAX | 10 | $0 | $13,399 | $13,399 |
| OAPAE-OAP PLAN ALL EMPLOYEES | E1211-EXECUTIVES/ELECTED OFFICIALS | 2 | R | CH | M | 1-17 | J939 | PNEUMOTHORAX, UNSPECIFIED | 10 | $0 | $153,039 | $153,039 |
| $0 | $166,438 | $166,438 | ||||||||||
| OAPAE-OAP PLAN ALL EMPLOYEES | NAGEN-ACTIVE EMPLOYEES (GENERAL) | 2 | R | EE | M | 50-59 | M064 | INFLAMMATORY POLYARTHROPATHY | 10 | $101,147 | $463 | $101,610 |
| NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES) | NAGEN-ACTIVE EMPLOYEES (GENERAL) | 2 | R | SP | F | 30-39 | O09513 | SUPERVISION OF ELDERLY PRIMIGRAVIDA, THIRD TRIMESTER | 10 | $157 | $405 | $563 |
| OAPAE-OAP PLAN ALL EMPLOYEES | NAGEN-ACTIVE EMPLOYEES (GENERAL) | 2 | R | SP | F | 30-39 | J4541 | MODERATE PERSISTENT ASTHMA WITH (ACUTE) EXACERBATION | 10 | $17,485 | $35,486 | $52,971 |
| $17,642 | $35,892 | $53,534 | ||||||||||
| OAPAE-OAP PLAN ALL EMPLOYEES | NAGEN-ACTIVE EMPLOYEES (GENERAL) | 2 | R | SP | F | 60-64 | Z5111 | ENCOUNTER FOR ANTINEOPLASTIC CHEMOTHERAPY | 10 | $0 | $161,689 | $161,689 |
| NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES) | NAGEN-ACTIVE EMPLOYEES (GENERAL) | 2 | R | EE | F | 40-49 | R000 | TACHYCARDIA, UNSPECIFIED | 10 | ($18) | $30 | $12 |
| OAPAE-OAP PLAN ALL EMPLOYEES | NAGEN-ACTIVE EMPLOYEES (GENERAL) | 2 | R | EE | F | 40-49 | D62 | ACUTE POSTHEMORRHAGIC ANEMIA | 10 | $8,029 | $54,688 | $62,716 |
| $8,010 | $54,718 | $62,728 | ||||||||||
| NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES) | NAGEN-ACTIVE EMPLOYEES (GENERAL) | 2 | R | EE | F | 40-49 | G35 | MULTIPLE SCLEROSIS | 10 | $0 | $13,501 | $13,501 |
| OAPAE-OAP PLAN ALL EMPLOYEES | NAGEN-ACTIVE EMPLOYEES (GENERAL) | 2 | R | EE | F | 40-49 | G35 | MULTIPLE SCLEROSIS | 10 | $9,073 | $114,096 | $123,169 |
| $9,073 | $127,597 | $136,670 | ||||||||||
| OAPAE-OAP PLAN ALL EMPLOYEES | NAMC-ACTIVE EMPLOYEES (M/C) | 2 | R | CH | M | 1-17 | Q2111 | SECUNDUM ATRIAL SEPTAL DEFECT | 10 | $0 | $85,570 | $85,570 |
| NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES) | E1211-EXECUTIVES/ELECTED OFFICIALS | 2 | R | EE | F | 30-39 | O99012 | ANEMIA COMPLICATING PREGNANCY, SECOND TRIMESTER | 10 | $88 | $736 | $824 |
| OAPAE-OAP PLAN ALL EMPLOYEES | E1211-EXECUTIVES/ELECTED OFFICIALS | 2 | R | EE | F | 30-39 | O1414 | SEVERE PRE-ECLAMPSIA COMPLICATING CHILDBIRTH | 10 | $2,057 | $135,459 | $137,516 |
| $2,145 | $136,195 | $138,340 | ||||||||||
| OAPAE-OAP PLAN ALL EMPLOYEES | NAMC-ACTIVE EMPLOYEES (M/C) | 1 | M | EE | F | 60-64 | * | UNSPECIFIED | * | $0 | $21,817 | $21,817 |
| OAPAE-OAP PLAN ALL EMPLOYEES | NAMC-ACTIVE EMPLOYEES (M/C) | 2 | R | EE | F | 60-64 | A419 | SEPSIS, UNSPECIFIED ORGANISM | 10 | $596 | $349,404 | $350,000 |
| $596 | $371,221 | $371,817 | ||||||||||
| NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES) | NAGEN-ACTIVE EMPLOYEES (GENERAL) | 1 | M | EE | F | 50-59 | * | UNSPECIFIED | * | $0 | $11 | $11 |
| NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES) | NAGEN-ACTIVE EMPLOYEES (GENERAL) | 2 | R | EE | F | 50-59 | Z5112 | ENCOUNTER FOR ANTINEOPLASTIC IMMUNOTHERAPY | 10 | $0 | $122,910 | $122,910 |
| OAPAE-OAP PLAN ALL EMPLOYEES | NAGEN-ACTIVE EMPLOYEES (GENERAL) | 1 | M | EE | F | 50-59 | * | UNSPECIFIED | * | $0 | $423,767 | $423,767 |
| OAPAE-OAP PLAN ALL EMPLOYEES | NAGEN-ACTIVE EMPLOYEES (GENERAL) | 2 | R | EE | F | 50-59 | C50811 | MALIGNANT NEOPLASM OF OVRLP SITES OF RIGHT FEMALE BREAST | 10 | $132 | $226,650 | $226,782 |
| $132 | $773,338 | $773,470 | ||||||||||
| NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES) | NAMC-ACTIVE EMPLOYEES (M/C) | 2 | R | EE | F | 60-64 | M542 | CERVICALGIA | 10 | $0 | $3,941 | $3,941 |
| OAPAE-OAP PLAN ALL EMPLOYEES | NAMC-ACTIVE EMPLOYEES (M/C) | 2 | R | EE | F | 60-64 | R079 | CHEST PAIN, UNSPECIFIED | 10 | $68,966 | $15,308 | $84,274 |
| $68,966 | $19,248 | $88,214 | ||||||||||
| OAPAE-OAP PLAN ALL EMPLOYEES | E1211-EXECUTIVES/ELECTED OFFICIALS | 2 | R | EE | F | 50-59 | Z0001 | ENCOUNTER FOR GENERAL ADULT MEDICAL EXAM W ABNORMAL FINDINGS | 10 | $64,057 | $393 | $64,450 |
| NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES) | NRETG1-NON-MEDICARE RETIREE - 65 W/ DEP - 65 | 2 | R | EE | F | 60-64 | PH | PHARMACY | * | $70 | $0 | $70 |
| OAPAE-OAP PLAN ALL EMPLOYEES | NRETG1-NON-MEDICARE RETIREE - 65 W/ DEP - 65 | 2 | R | EE | F | 60-64 | D251 | INTRAMURAL LEIOMYOMA OF UTERUS | 10 | $13,579 | $38,593 | $52,172 |
| $13,649 | $38,593 | $52,242 | ||||||||||
| NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES) | NAGEN-ACTIVE EMPLOYEES (GENERAL) | 2 | R | SP | F | 65+ | PH | PHARMACY | * | ($255) | $0 | ($255) |
| OAPAE-OAP PLAN ALL EMPLOYEES | NAGEN-ACTIVE EMPLOYEES (GENERAL) | 2 | R | SP | F | 65+ | I110 | HYPERTENSIVE HEART DISEASE WITH HEART FAILURE | 10 | $4,471 | $71,429 | $75,900 |
| $4,216 | $71,429 | $75,645 | ||||||||||
| NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES) | NAMC-ACTIVE EMPLOYEES (M/C) | 2 | R | EE | M | 65+ | A4152 | SEPSIS DUE TO PSEUDOMONAS | 10 | $0 | $70,467 | $70,467 |
| OAPAE-OAP PLAN ALL EMPLOYEES | NAMC-ACTIVE EMPLOYEES (M/C) | 1 | M | EE | M | 65+ | * | UNSPECIFIED | * | $0 | $310,717 | $310,717 |
| OAPAE-OAP PLAN ALL EMPLOYEES | NAMC-ACTIVE EMPLOYEES (M/C) | 2 | R | EE | M | 65+ | Z5112 | ENCOUNTER FOR ANTINEOPLASTIC IMMUNOTHERAPY | 10 | $167,138 | $112,047 | $279,185 |
| $167,138 | $493,232 | $660,369 | ||||||||||
| OAPAE-OAP PLAN ALL EMPLOYEES | NAGEN-ACTIVE EMPLOYEES (GENERAL) | 2 | R | CH | F | 18-29 | O365930 | MATERN CARE FOR OTH OR SUSP POOR FETL GRTH, THIRD TRI, UNSP | 10 | $283 | $59,543 | $59,826 |
| NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES) | NAGEN-ACTIVE EMPLOYEES (GENERAL) | 1 | M | SP | M | 65+ | * | UNSPECIFIED | * | $0 | $8,852 | $8,852 |
| NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES) | NAGEN-ACTIVE EMPLOYEES (GENERAL) | 2 | R | SP | M | 65+ | Z5111 | ENCOUNTER FOR ANTINEOPLASTIC CHEMOTHERAPY | 10 | $46 | $47,880 | $47,927 |
| OAPAE-OAP PLAN ALL EMPLOYEES | NAGEN-ACTIVE EMPLOYEES (GENERAL) | 1 | M | SP | M | 65+ | * | UNSPECIFIED | * | $0 | $217,214 | $217,214 |
| OAPAE-OAP PLAN ALL EMPLOYEES | NAGEN-ACTIVE EMPLOYEES (GENERAL) | 2 | R | SP | M | 65+ | K831 | OBSTRUCTION OF BILE DUCT | 10 | $1,864 | $299,303 | $301,167 |
| $1,910 | $573,249 | $575,160 | ||||||||||
| NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES) | NAMC-ACTIVE EMPLOYEES (M/C) | 2 | R | EE | M | 65+ | M542 | CERVICALGIA | 10 | $0 | $245 | $245 |
| OAPAE-OAP PLAN ALL EMPLOYEES | NAMC-ACTIVE EMPLOYEES (M/C) | 2 | R | EE | M | 65+ | K5732 | DVTRCLI OF LG INT W/O PERFORATION OR ABSCESS W/O BLEEDING | 10 | $1,541 | $66,322 | $67,863 |
| $1,541 | $66,567 | $68,108 | ||||||||||
| OAPAE-OAP PLAN ALL EMPLOYEES | NAGEN-ACTIVE EMPLOYEES (GENERAL) | 2 | R | CH | F | 18-29 | Q048 | OTHER SPECIFIED CONGENITAL MALFORMATIONS OF BRAIN | 10 | $1,479 | $79,366 | $80,845 |
| NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES) | NAGEN-ACTIVE EMPLOYEES (GENERAL) | 2 | R | EE | F | 18-29 | R0602 | SHORTNESS OF BREATH | 10 | $0 | $1,871 | $1,871 |
| OAPAE-OAP PLAN ALL EMPLOYEES | NAGEN-ACTIVE EMPLOYEES (GENERAL) | 2 | R | EE | F | 18-29 | E1065 | TYPE 1 DIABETES MELLITUS WITH HYPERGLYCEMIA | 10 | $910 | $129,793 | $130,702 |
| $910 | $131,664 | $132,573 | ||||||||||
| NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES) | NAGEN-ACTIVE EMPLOYEES (GENERAL) | 2 | R | SP | M | 50-59 | Z0000 | ENCNTR FOR GENERAL ADULT MEDICAL EXAM W/O ABNORMAL FINDINGS | 10 | $0 | $181 | $181 |
| OAPAE-OAP PLAN ALL EMPLOYEES | NAGEN-ACTIVE EMPLOYEES (GENERAL) | 2 | R | SP | M | 50-59 | R0981 | NASAL CONGESTION | 10 | $59,705 | $1,561 | $61,266 |
| $59,705 | $1,742 | $61,447 | ||||||||||
| NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES) | NAGEN-ACTIVE EMPLOYEES (GENERAL) | 2 | R | EE | M | 60-64 | L600 | INGROWING NAIL | 10 | $39 | $46 | $85 |
| OAPAE-OAP PLAN ALL EMPLOYEES | NAGEN-ACTIVE EMPLOYEES (GENERAL) | 2 | R | EE | M | 60-64 | A419 | SEPSIS, UNSPECIFIED ORGANISM | 10 | $5,930 | $59,427 | $65,358 |
| $5,969 | $59,473 | $65,442 | ||||||||||
| NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES) | NAGEN-ACTIVE EMPLOYEES (GENERAL) | 2 | R | EE | F | 60-64 | L0231 | CUTANEOUS ABSCESS OF BUTTOCK | 10 | $0 | $30,481 | $30,481 |
| OAPAE-OAP PLAN ALL EMPLOYEES | NAGEN-ACTIVE EMPLOYEES (GENERAL) | 2 | R | EE | F | 60-64 | F411 | GENERALIZED ANXIETY DISORDER | 10 | $253 | $31,193 | $31,445 |
| $253 | $61,673 | $61,926 | ||||||||||
| NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES) | NAGEN-ACTIVE EMPLOYEES (GENERAL) | 2 | R | EE | F | 60-64 | Z01419 | ENCNTR FOR GYN EXAM (GENERAL) (ROUTINE) W/O ABN FINDINGS | 10 | $2,472 | $592 | $3,064 |
| OAPAE-OAP PLAN ALL EMPLOYEES | NAGEN-ACTIVE EMPLOYEES (GENERAL) | 2 | R | EE | F | 60-64 | N840 | POLYP OF CORPUS UTERI | 10 | $7,497 | $67,245 | $74,743 |
| $9,970 | $67,837 | $77,806 | ||||||||||
| OAPAE-OAP PLAN ALL EMPLOYEES | NAGEN-ACTIVE EMPLOYEES (GENERAL) | 2 | R | CH | M | 1-17 | R6252 | SHORT STATURE (CHILD) | 10 | $64,462 | $1,494 | $65,956 |
| NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES) | NASEA-ACTIVE EMPLOYEES (SEA) | 2 | R | CH | M | 1-17 | L02419 | CUTANEOUS ABSCESS OF LIMB, UNSPECIFIED | 10 | $0 | $1,424 | $1,424 |
| OAPAE-OAP PLAN ALL EMPLOYEES | NASEA-ACTIVE EMPLOYEES (SEA) | 2 | R | CH | M | 1-17 | S82392B | OTH FX LOWER END OF LEFT TIBIA, INIT FOR OPN FX TYPE I/2 | 10 | $643 | $146,068 | $146,711 |
| $643 | $147,491 | $148,135 | ||||||||||
| NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES) | NAGEN-ACTIVE EMPLOYEES (GENERAL) | 2 | R | CH | F | 1-17 | G119 | HEREDITARY ATAXIA, UNSPECIFIED | 10 | $0 | $2,335 | $2,335 |
| OAPAE-OAP PLAN ALL EMPLOYEES | NAGEN-ACTIVE EMPLOYEES (GENERAL) | 2 | R | CH | F | 1-17 | D3616 | BENIGN NEOPLM OF PRPH NERVES AND AUTONM NRV SYS OF PELVIS | 10 | $27 | $149,315 | $149,342 |
| $27 | $151,649 | $151,677 | ||||||||||
| NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES) | NASEA-ACTIVE EMPLOYEES (SEA) | 2 | R | EE | F | 40-49 | M3214 | GLOMERULAR DISEASE IN SYSTEMIC LUPUS ERYTHEMATOSUS | 10 | $0 | $26,328 | $26,328 |
| OAPAE-OAP PLAN ALL EMPLOYEES | NASEA-ACTIVE EMPLOYEES (SEA) | 2 | R | EE | F | 40-49 | M3214 | GLOMERULAR DISEASE IN SYSTEMIC LUPUS ERYTHEMATOSUS | 10 | $5,815 | $148,167 | $153,982 |
| $5,815 | $174,495 | $180,310 | ||||||||||
| NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES) | NAGEN-ACTIVE EMPLOYEES (GENERAL) | 2 | R | EE | F | 65+ | R29898 | OTH SYMPTOMS AND SIGNS INVOLVING THE MUSCULOSKELETAL SYSTEM | 10 | ($41) | $517 | $477 |
| OAPAE-OAP PLAN ALL EMPLOYEES | NAGEN-ACTIVE EMPLOYEES (GENERAL) | 2 | R | EE | F | 65+ | R001 | BRADYCARDIA, UNSPECIFIED | 10 | $453 | $53,698 | $54,151 |
| $412 | $54,216 | $54,628 | ||||||||||
| NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES) | NAGEN-ACTIVE EMPLOYEES (GENERAL) | 2 | R | EE | M | 50-59 | M5116 | INTERVERTEBRAL DISC DISORDERS W RADICULOPATHY, LUMBAR REGION | 10 | $0 | $50 | $50 |
| OAPAE-OAP PLAN ALL EMPLOYEES | NAGEN-ACTIVE EMPLOYEES (GENERAL) | 2 | R | EE | M | 50-59 | M5116 | INTERVERTEBRAL DISC DISORDERS W RADICULOPATHY, LUMBAR REGION | 10 | $59,924 | $76,618 | $136,542 |
| $59,924 | $76,668 | $136,592 | ||||||||||
| NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES) | NAGEN-ACTIVE EMPLOYEES (GENERAL) | 1 | M | EE | F | 60-64 | * | UNSPECIFIED | * | $0 | $10 | $10 |
| NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES) | NAGEN-ACTIVE EMPLOYEES (GENERAL) | 2 | R | EE | F | 60-64 | C7951 | SECONDARY MALIGNANT NEOPLASM OF BONE | 10 | $0 | $12,287 | $12,287 |
| OAPAE-OAP PLAN ALL EMPLOYEES | NAGEN-ACTIVE EMPLOYEES (GENERAL) | 2 | R | EE | F | 60-64 | Z5112 | ENCOUNTER FOR ANTINEOPLASTIC IMMUNOTHERAPY | 10 | $404 | $206,427 | $206,831 |
| $404 | $218,724 | $219,128 | ||||||||||
| OAPAE-OAP PLAN ALL EMPLOYEES | NAGEN-ACTIVE EMPLOYEES (GENERAL) | 2 | R | EE | F | 40-49 | PH | PHARMACY | * | $402 | $0 | $402 |
| OAPAE-OAP PLAN ALL EMPLOYEES | NAGEN-ACTIVE EMPLOYEES (GENERAL) | 2 | R | EE | M | 40-49 | M5117 | INTVRT DISC DISORDERS W RADICULOPATHY, LUMBOSACRAL REGION | 10 | $0 | $49,902 | $49,902 |
| $402 | $49,902 | $50,304 | ||||||||||
| NPOS2-STANDALONE NETWORK POS PLAN COPY NO RX | RMEPDP-RETIRED MEDICARE ELIGIBLE W/PDP PLAN | 2 | R | EE | F | 65+ | L89221 | PRESSURE ULCER OF LEFT HIP, STAGE 1 | 10 | $0 | $374 | $374 |
| OAPNX-OAP PLAN NO RX | RMEPDP-RETIRED MEDICARE ELIGIBLE W/PDP PLAN | 2 | R | EE | F | 65+ | L89214 | PRESSURE ULCER OF RIGHT HIP, STAGE 4 | 10 | $0 | $103,277 | $103,277 |
| $0 | $103,650 | $103,650 | ||||||||||
| OAPAE-OAP PLAN ALL EMPLOYEES | NAGEN-ACTIVE EMPLOYEES (GENERAL) | 2 | R | EE | M | 60-64 | I4710 | SUPRAVENTRICULAR TACHYCARDIA, UNSPECIFIED | 10 | $10,150 | $57,256 | $67,406 |
| NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES) | NAGEN-ACTIVE EMPLOYEES (GENERAL) | 2 | R | EE | M | 40-49 | PH | PHARMACY | * | $966 | $0 | $966 |
| OAPAE-OAP PLAN ALL EMPLOYEES | NAGEN-ACTIVE EMPLOYEES (GENERAL) | 2 | R | EE | M | 40-49 | M75121 | COMPLETE ROTATR-CUFF TEAR/RUPTR OF R SHOULDER, NOT TRAUMA | 10 | $14,093 | $36,326 | $50,418 |
| $15,059 | $36,326 | $51,385 | ||||||||||
| NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES) | NAGEN-ACTIVE EMPLOYEES (GENERAL) | 2 | R | EE | F | 50-59 | I2510 | ATHSCL HEART DISEASE OF NATIVE CORONARY ARTERY W/O ANG PCTRS | 10 | $0 | $62,303 | $62,303 |
| NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES) | NAGEN-ACTIVE EMPLOYEES (GENERAL) | 2 | R | EE | F | 60-64 | Z1211 | ENCOUNTER FOR SCREENING FOR MALIGNANT NEOPLASM OF COLON | 10 | $0 | $5,042 | $5,042 |
| OAPAE-OAP PLAN ALL EMPLOYEES | NAGEN-ACTIVE EMPLOYEES (GENERAL) | 2 | R | EE | F | 60-64 | K449 | DIAPHRAGMATIC HERNIA WITHOUT OBSTRUCTION OR GANGRENE | 10 | $12,066 | $2,121 | $14,187 |
| $12,066 | $69,466 | $81,531 | ||||||||||
| OAPAE-OAP PLAN ALL EMPLOYEES | NAGEN-ACTIVE EMPLOYEES (GENERAL) | 2 | R | SP | M | 50-59 | N4289 | OTHER SPECIFIED DISORDERS OF PROSTATE | 10 | $60,484 | $4,342 | $64,826 |
| NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES) | NAGEN-ACTIVE EMPLOYEES (GENERAL) | 2 | R | EE | F | 50-59 | PH | PHARMACY | * | ($19) | $0 | ($19) |
| OAPAE-OAP PLAN ALL EMPLOYEES | NAGEN-ACTIVE EMPLOYEES (GENERAL) | 2 | R | EE | F | 50-59 | Z5111 | ENCOUNTER FOR ANTINEOPLASTIC CHEMOTHERAPY | 10 | $41,076 | $60,757 | $101,832 |
| $41,056 | $60,757 | $101,813 | ||||||||||
| NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES) | NAGEN-ACTIVE EMPLOYEES (GENERAL) | 2 | R | SP | F | 30-39 | O98512 | OTH VIRAL DISEASES COMPLICATING PREGNANCY, SECOND TRIMESTER | 10 | $19 | $1,701 | $1,720 |
| OAPAE-OAP PLAN ALL EMPLOYEES | NAGEN-ACTIVE EMPLOYEES (GENERAL) | 2 | R | SP | F | 30-39 | O1404 | MILD TO MODERATE PRE-ECLAMPSIA, COMPLICATING CHILDBIRTH | 10 | $624 | $80,679 | $81,302 |
| $643 | $82,380 | $83,023 | ||||||||||
| NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES) | NAGEN-ACTIVE EMPLOYEES (GENERAL) | 2 | R | SP | F | 60-64 | J069 | ACUTE UPPER RESPIRATORY INFECTION, UNSPECIFIED | 10 | $0 | $30 | $30 |
| OAPAE-OAP PLAN ALL EMPLOYEES | NAGEN-ACTIVE EMPLOYEES (GENERAL) | 2 | R | SP | F | 60-64 | K5720 | DVTRCLI OF LG INT W PERFORATION AND ABSCESS W/O BLEEDING | 10 | $417 | $232,689 | $233,106 |
| $417 | $232,719 | $233,136 | ||||||||||
| NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES) | NAGEN-ACTIVE EMPLOYEES (GENERAL) | 2 | R | CH | F | 18-29 | M62838 | OTHER MUSCLE SPASM | 10 | $0 | $190 | $190 |
| OAPAE-OAP PLAN ALL EMPLOYEES | NAGEN-ACTIVE EMPLOYEES (GENERAL) | 2 | R | CH | F | 18-29 | R252 | CRAMP AND SPASM | 10 | $189 | $81,227 | $81,416 |
| $189 | $81,417 | $81,606 | ||||||||||
| OAPAE-OAP PLAN ALL EMPLOYEES | NAGEN-ACTIVE EMPLOYEES (GENERAL) | 2 | R | SP | F | 30-39 | G43909 | MIGRAINE, UNSP, NOT INTRACTABLE, WITHOUT STATUS MIGRAINOSUS | 10 | $60,614 | $67 | $60,681 |
| NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES) | NAMC-ACTIVE EMPLOYEES (M/C) | 2 | R | EE | M | 65+ | PH | PHARMACY | * | $792 | $0 | $792 |
| OAPAE-OAP PLAN ALL EMPLOYEES | NAMC-ACTIVE EMPLOYEES (M/C) | 2 | R | EE | M | 65+ | I7121 | ANEURYSM OF THE ASCENDING AORTA, WITHOUT RUPTURE | 10 | $6,248 | $198,916 | $205,164 |
| $7,040 | $198,916 | $205,955 | ||||||||||
| OAPAE-OAP PLAN ALL EMPLOYEES | NAGEN-ACTIVE EMPLOYEES (GENERAL) | 2 | R | CH | M | 18-29 | I609 | NONTRAUMATIC SUBARACHNOID HEMORRHAGE, UNSPECIFIED | 10 | $122 | $129,875 | $129,997 |
| NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES) | NAGEN-ACTIVE EMPLOYEES (GENERAL) | 2 | R | EE | M | 50-59 | E11621 | TYPE 2 DIABETES MELLITUS WITH FOOT ULCER | 10 | $1,209 | $4,310 | $5,519 |
| OAPAE-OAP PLAN ALL EMPLOYEES | NAGEN-ACTIVE EMPLOYEES (GENERAL) | 2 | R | EE | M | 50-59 | I420 | DILATED CARDIOMYOPATHY | 10 | $19,760 | $90,804 | $110,565 |
| $20,969 | $95,114 | $116,084 | ||||||||||
| OAPAE-OAP PLAN ALL EMPLOYEES | NAGEN-ACTIVE EMPLOYEES (GENERAL) | 2 | R | SP | F | 40-49 | D259 | LEIOMYOMA OF UTERUS, UNSPECIFIED | 10 | $1,230 | $74,146 | $75,376 |
| OAPAE-OAP PLAN ALL EMPLOYEES | NAGEN-ACTIVE EMPLOYEES (GENERAL) | 2 | R | EE | M | 50-59 | B20 | HUMAN IMMUNODEFICIENCY VIRUS [HIV] DISEASE | 10 | $51,263 | $1,714 | $52,977 |
| OAPAE-OAP PLAN ALL EMPLOYEES | NAGEN-ACTIVE EMPLOYEES (GENERAL) | 2 | R | CH | M | <-1 | Z3801 | SINGLE LIVEBORN INFANT, DELIVERED BY CESAREAN | 10 | $0 | $132,539 | $132,539 |
| NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES) | NAGEN-ACTIVE EMPLOYEES (GENERAL) | 2 | R | CH | M | 18-29 | S72351B | DISPL COMMNT FX SHAFT OF R FEMUR, INIT FOR OPN FX TYPE I/2 | 10 | $0 | $61,236 | $61,236 |
| OAPAE-OAP PLAN ALL EMPLOYEES | NAGEN-ACTIVE EMPLOYEES (GENERAL) | 2 | R | CH | M | 18-29 | R072 | PRECORDIAL PAIN | 10 | $5 | $4,873 | $4,878 |
| $5 | $66,109 | $66,114 | ||||||||||
| NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES) | NRETG1-NON-MEDICARE RETIREE - 65 W/ DEP - 65 | 2 | R | EE | F | 60-64 | N186 | END STAGE RENAL DISEASE | 10 | $0 | $8,262 | $8,262 |
| OAPAE-OAP PLAN ALL EMPLOYEES | NRETG1-NON-MEDICARE RETIREE - 65 W/ DEP - 65 | 2 | R | EE | F | 60-64 | N186 | END STAGE RENAL DISEASE | 10 | $24,894 | $100,431 | $125,325 |
| $24,894 | $108,693 | $133,587 | ||||||||||
| NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES) | NAGEN-ACTIVE EMPLOYEES (GENERAL) | 2 | R | EE | F | 50-59 | J209 | ACUTE BRONCHITIS, UNSPECIFIED | 10 | $21 | $685 | $706 |
| OAPAE-OAP PLAN ALL EMPLOYEES | NAGEN-ACTIVE EMPLOYEES (GENERAL) | 2 | R | EE | F | 50-59 | K650 | GENERALIZED (ACUTE) PERITONITIS | 10 | $187 | $83,186 | $83,374 |
| $209 | $83,871 | $84,079 | ||||||||||
| OAPAE-OAP PLAN ALL EMPLOYEES | E1211-EXECUTIVES/ELECTED OFFICIALS | 2 | R | CH | F | 18-29 | K5010 | CROHN'S DISEASE OF LARGE INTESTINE WITHOUT COMPLICATIONS | 10 | $202,094 | $4,967 | $207,061 |
| OAPAE-OAP PLAN ALL EMPLOYEES | NAGEN-ACTIVE EMPLOYEES (GENERAL) | 2 | R | CH | M | 18-29 | S61211A | LACERATION W/O FB OF L IDX FNGR W/O DAMAGE TO NAIL, INIT | 10 | $54,088 | $4,502 | $58,590 |
| NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES) | NAGEN-ACTIVE EMPLOYEES (GENERAL) | 2 | R | EE | F | 60-64 | PH | PHARMACY | * | $29 | $0 | $29 |
| OAPAE-OAP PLAN ALL EMPLOYEES | NAGEN-ACTIVE EMPLOYEES (GENERAL) | 2 | R | EE | F | 60-64 | M4317 | SPONDYLOLISTHESIS, LUMBOSACRAL REGION | 10 | $688 | $85,535 | $86,222 |
| $717 | $85,535 | $86,251 | ||||||||||
| NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES) | E1211-EXECUTIVES/ELECTED OFFICIALS | 2 | R | SP | F | 40-49 | Z03818 | ENCNTR FOR OBS FOR SUSP EXPSR TO OTH BIOLG AGENTS RULED OUT | 10 | $0 | $90 | $90 |
| OAPAE-OAP PLAN ALL EMPLOYEES | E1211-EXECUTIVES/ELECTED OFFICIALS | 2 | R | SP | F | 40-49 | K5100 | ULCERATIVE (CHRONIC) PANCOLITIS WITHOUT COMPLICATIONS | 10 | $261,368 | $8,284 | $269,652 |
| $261,368 | $8,374 | $269,742 | ||||||||||
| OAPNX-OAP PLAN NO RX | RMEPDP-RETIRED MEDICARE ELIGIBLE W/PDP PLAN | 2 | R | EE | M | 65+ | J9610 | CHRONIC RESPIRATORY FAILURE, UNSP W HYPOXIA OR HYPERCAPNIA | 10 | $0 | $94,607 | $94,607 |
| NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES) | E1211-EXECUTIVES/ELECTED OFFICIALS | 2 | R | SP | M | 50-59 | I5021 | ACUTE SYSTOLIC (CONGESTIVE) HEART FAILURE | 10 | $19 | $12,844 | $12,863 |
| OAPAE-OAP PLAN ALL EMPLOYEES | E1211-EXECUTIVES/ELECTED OFFICIALS | 2 | R | SP | M | 50-59 | I428 | OTHER CARDIOMYOPATHIES | 10 | $7,663 | $120,738 | $128,401 |
| $7,682 | $133,582 | $141,265 | ||||||||||
| NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES) | NAGEN-ACTIVE EMPLOYEES (GENERAL) | 2 | R | EE | F | 60-64 | M5450 | LOW BACK PAIN, UNSPECIFIED | 10 | $0 | $4,620 | $4,620 |
| OAPAE-OAP PLAN ALL EMPLOYEES | NAGEN-ACTIVE EMPLOYEES (GENERAL) | 2 | R | EE | F | 60-64 | L03115 | CELLULITIS OF RIGHT LOWER LIMB | 10 | $5,839 | $49,993 | $55,832 |
| $5,839 | $54,613 | $60,452 | ||||||||||
| NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES) | NAMC-ACTIVE EMPLOYEES (M/C) | 2 | R | EE | M | 50-59 | I471 | SUPRAVENTRICULAR TACHYCARDIA | 10 | $0 | $221 | $221 |
| OAPAE-OAP PLAN ALL EMPLOYEES | NAMC-ACTIVE EMPLOYEES (M/C) | 2 | R | EE | M | 50-59 | U071 | COVID-19 | 10 | $4,690 | $74,924 | $79,614 |
| OAPAE-OAP PLAN ALL EMPLOYEES | NAMC-ACTIVE EMPLOYEES (M/C) | 2 | R | EE | M | 60-64 | M25561 | PAIN IN RIGHT KNEE | 10 | $7,862 | $632 | $8,494 |
| $12,552 | $75,777 | $88,329 | ||||||||||
| NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES) | NAGEN-ACTIVE EMPLOYEES (GENERAL) | 2 | R | EE | F | 65+ | PH | PHARMACY | * | $60 | $0 | $60 |
| OAPAE-OAP PLAN ALL EMPLOYEES | NAGEN-ACTIVE EMPLOYEES (GENERAL) | 2 | R | EE | F | 65+ | M19072 | PRIMARY OSTEOARTHRITIS, LEFT ANKLE AND FOOT | 10 | $165,990 | $1,416 | $167,405 |
| $166,050 | $1,416 | $167,465 | ||||||||||
| NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES) | NAMC-ACTIVE EMPLOYEES (M/C) | 1 | M | EE | F | 50-59 | * | UNSPECIFIED | * | $0 | $19 | $19 |
| NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES) | NAMC-ACTIVE EMPLOYEES (M/C) | 2 | R | EE | F | 50-59 | Z01419 | ENCNTR FOR GYN EXAM (GENERAL) (ROUTINE) W/O ABN FINDINGS | 10 | $46 | $101 | $147 |
| OAPAE-OAP PLAN ALL EMPLOYEES | NAMC-ACTIVE EMPLOYEES (M/C) | 1 | M | EE | F | 50-59 | * | UNSPECIFIED | * | $0 | $207,081 | $207,081 |
| OAPAE-OAP PLAN ALL EMPLOYEES | NAMC-ACTIVE EMPLOYEES (M/C) | 2 | R | EE | F | 50-59 | C7949 | SECONDARY MALIGNANT NEOPLASM OF OTH PARTS OF NERVOUS SYSTEM | 10 | $90,638 | $259,355 | $349,993 |
| $90,685 | $466,556 | $557,241 | ||||||||||
| NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES) | E1211-EXECUTIVES/ELECTED OFFICIALS | 2 | R | CH | M | 1-17 | K5090 | CROHN'S DISEASE, UNSPECIFIED, WITHOUT COMPLICATIONS | 10 | $6,793 | $698 | $7,491 |
| OAPAE-OAP PLAN ALL EMPLOYEES | E1211-EXECUTIVES/ELECTED OFFICIALS | 2 | R | CH | M | 1-17 | S0101XA | LACERATION WITHOUT FOREIGN BODY OF SCALP, INITIAL ENCOUNTER | 10 | $106,681 | $2,311 | $108,991 |
| $113,473 | $3,009 | $116,482 | ||||||||||
| NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES) | NASEA-ACTIVE EMPLOYEES (SEA) | 2 | R | CH | F | 18-29 | Z31430 | ENCNTR FEM FOR TEST FOR GENETC DIS CARRIER STAT FOR PRO MGMT | 10 | $0 | $5,759 | $5,759 |
| OAPAE-OAP PLAN ALL EMPLOYEES | NASEA-ACTIVE EMPLOYEES (SEA) | 2 | R | CH | F | 18-29 | O99891 | OTH DISEASES AND CONDITIONS COMPLICATING PREGNANCY | 10 | $56 | $46,249 | $46,305 |
| $56 | $52,008 | $52,064 | ||||||||||
| NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES) | NAGEN-ACTIVE EMPLOYEES (GENERAL) | 2 | R | SP | F | 65+ | Z1231 | ENCNTR SCREEN MAMMOGRAM FOR MALIGNANT NEOPLASM OF BREAST | 10 | $4,493 | $275 | $4,768 |
| OAPAE-OAP PLAN ALL EMPLOYEES | NAGEN-ACTIVE EMPLOYEES (GENERAL) | 2 | R | SP | F | 65+ | C7931 | SECONDARY MALIGNANT NEOPLASM OF BRAIN | 10 | $1,693 | $103,432 | $105,125 |
| $6,186 | $103,707 | $109,893 | ||||||||||
| NPOS2-STANDALONE NETWORK POS PLAN COPY NO RX | RMEPDP-RETIRED MEDICARE ELIGIBLE W/PDP PLAN | 2 | R | EE | M | 60-64 | E119 | TYPE 2 DIABETES MELLITUS WITHOUT COMPLICATIONS | 10 | $0 | ($66,009) | ($66,009) |
| NPOS2-STANDALONE NETWORK POS PLAN COPY NO RX | RMEPDP-RETIRED MEDICARE ELIGIBLE W/PDP PLAN | 2 | R | EE | M | 65+ | E113413 | TYPE 2 DIAB WITH SEVERE NONP RTNOP WITH MACULAR EDEMA, BI | 10 | $0 | $536 | $536 |
| OAPNX-OAP PLAN NO RX | RMEPDP-RETIRED MEDICARE ELIGIBLE W/PDP PLAN | 2 | R | EE | M | 65+ | G6181 | CHRONIC INFLAMMATORY DEMYELINATING POLYNEURITIS | 10 | $0 | $237,611 | $237,611 |
| $0 | $172,138 | $172,138 | ||||||||||
| NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES) | NAGEN-ACTIVE EMPLOYEES (GENERAL) | 2 | R | SP | M | 30-39 | C787 | SECONDARY MALIG NEOPLASM OF LIVER AND INTRAHEPATIC BILE DUCT | 10 | $0 | $59,955 | $59,955 |
| NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES) | NAGEN-ACTIVE EMPLOYEES (GENERAL) | 2 | R | SP | F | 40-49 | C50912 | MALIGNANT NEOPLASM OF UNSPECIFIED SITE OF LEFT FEMALE BREAST | 10 | $0 | $8,835 | $8,835 |
| OAPAE-OAP PLAN ALL EMPLOYEES | NAGEN-ACTIVE EMPLOYEES (GENERAL) | 2 | R | SP | F | 40-49 | C50212 | MALIG NEOPLASM OF UPPER-INNER QUADRANT OF LEFT FEMALE BREAST | 10 | $566 | $55,931 | $56,497 |
| $566 | $64,766 | $65,331 | ||||||||||
| NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES) | NAGEN-ACTIVE EMPLOYEES (GENERAL) | 1 | M | EE | M | 40-49 | * | UNSPECIFIED | * | $0 | ($13) | ($13) |
| NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES) | NAGEN-ACTIVE EMPLOYEES (GENERAL) | 1 | M | EE | M | 50-59 | * | UNSPECIFIED | * | $0 | $10 | $10 |
| NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES) | NAGEN-ACTIVE EMPLOYEES (GENERAL) | 2 | R | EE | M | 40-49 | K219 | GASTRO-ESOPHAGEAL REFLUX DISEASE WITHOUT ESOPHAGITIS | 10 | $0 | $47 | $47 |
| NPOS-NETWORK OPEN ACCESS POS (ALL EMPLOYEES) | NAGEN-ACTIVE EMPLOYEES (GENERAL) | 2 | R | EE | M | 50-59 | L03115 | CELLULITIS OF RIGHT LOWER LIMB | 10 | $0 | $26,957 | $26,957 |
| OAPAE-OAP PLAN ALL EMPLOYEES | NAGEN-ACTIVE EMPLOYEES (GENERAL) | 1 | M | EE | M | 50-59 | * | UNSPECIFIED | * | $0 | $61,120 | $61,120 |
| OAPAE-OAP PLAN ALL EMPLOYEES | NAGEN-ACTIVE EMPLOYEES (GENERAL) | 2 | R | EE | M | 50-59 | I480 | PAROXYSMAL ATRIAL FIBRILLATION | 10 | $52,678 | $269,724 | $322,402 |
This is the start of the file's text. The full file is on GovTribe.
File details come from the government source that posted it. Updated .